lemzoparlimab
![AbbVie Withdraws from CD47 Arena, Ending Partnership with I-Mab](https://pharmtales.com/wp-content/uploads/2023/09/AbbVie-Withdraws-from-CD47-Arena-Ending-Partnership-with-I-Mab.jpg)
AbbVie Withdraws from CD47 Arena, Ending Partnership with I-Mab
Anika Sharma
AbbVie has officially distanced itself from I-Mab, withdrawing from a once-promising collaboration focused on the anti-CD47 antibody lemzoparlimab, leaving I-Mab ...